Global Clinical Trial Management Market 2021-2028

As mentioned in this research report, the global market for clinical trial management is likely to register growth at a CAGR of 10.92% over the period of 2021-2028.

Factors such as an alarming rise in chronic diseases, a surge in R&D activities in the medical sector, and benefits offered by CTM software are stimulating the growth of the reviewed market over the forecasted period. Additionally, the increase in clinical trials is opening new avenues for the market during the registered period.

However, concerns regarding the security of CTM systems, along with the high initial cost of implementation, are limiting the global market’s growth. The high costs of installing and maintaining CTM software have made the researchers and pharmaceutical companies rethink investing in these systems, obstructing the market’s progress.

REGIONAL OUTLOOK

The global clinical trial management market covers North America, Asia-Pacific, Latin America, Europe, Middle East and Africa regions.
The Asia-Pacific is likely to become the fastest evolving market in the clinical trial management market over the estimated phase 2021-2028. The region’s strong growth can be attributed to its high population base, rising awareness about clinical management products, and the developing R&D sector. Moreover, the advanced healthcare infrastructure and surge in healthcare reforms are adding to the market’s growth.

Furthermore, the growing focus of leading manufacturers in expanding their geographic presence across the region are key factors generating new growth opportunities for the studied market.

COMPETITIVE OUTLOOK

The prominent enterprises in the clinical trial management market include Parexel International Corporation, Oracle Corporation, Advarra (Forte Research Systems Inc), Mednet Solutions Inc, Medidata Solutions Inc, Veeva Systems Inc, Arisglobal LLC, Bio-Optronics Inc, Bioclinica Inc, and IBM Corporation.
IBM Corporation is an information technology company offering integrated solutions. It conducts its business through segments, including cognitive solutions, global business services, technology services & cloud platforms, and others. Among its products, IBM clinical development is a platform featuring solutions that help gather, organize, analyze, and report data for type, size, or phase of the trial globally. With a broad consumer base globally, IBM is headquartered in New York, the United States.

Frequently Asked Questions about the Global Clinical Trial Management Market

What is the estimated value of the Global Clinical Trial Management Market?

The Global Clinical Trial Management Market was estimated to be valued at $876.26 million in 2021.

What is the growth rate of the Global Clinical Trial Management Market?

The growth rate of the Global Clinical Trial Management Market is 10.9%, with an estimated value of $1810.09 million by 2028.

What is the forecasted size of the Global Clinical Trial Management Market?

The Global Clinical Trial Management Market is estimated to be worth $1810.09 million by 2028.

Who are the key companies in the Global Clinical Trial Management Market?

Key companies in the Global Clinical Trial Management Market include Medidata Solutions Inc, Arisglobal LLC, Bioclinica Inc, Bio, Optronics Inc, Advarra (Forte Research Systems Inc), Oracle Corporation, IBM Corporation, Mednet Solutions Inc and Parexel International Corporation.

Report Attribute	Details
No. of Pages	162
Published	April 2021
Forecast Period	2021 - 2028
Estimated Market Value ( USD ) in 2021	$ 876.26 million
Forecasted Market Value ( USD ) by 2028	$ 1810.09 million
Compound Annual Growth Rate	10.9%
Regions Covered	Global

1. Global Clinical Trial Management Market - Summary

2. Industry Outlook

2.1. Market Scope
2.2. Key Insights
2.2.1. Enterprise-Based Ctm Contributes a Major Share in Product Type Segment
2.2.2. Healthcare Providers Are Rapidly Growing End-Users in the Market
2.2.3. Software is the Largest Component in the Clinical Trial Management Market
2.2.4. Cloud Model of Deployment is a Promising Segment in the Market
2.3. Porter's Five Forces Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Intensity of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Market Drivers
2.6.1. Alarming Rise in Chronic Diseases
2.6.2. Surge in Research & Development in the Medical Sector
2.6.3. Benefits Offered by Ctm Software
2.7. Market Restraints
2.7.1. Concerns Regarding the Security of Ctm Systems
2.7.2. Lack of Skilled Workforce
2.7.3. High Cost of Implementation
2.8. Market Opportunities
2.8.1. Growth in Clinical Trials
2.8.2. Outsourcing Clinical Trials for Cost Reduction
2.9. Key Strategic Developments
2.9.1. Merger & Acquisitions
2.9.2. Product Launch & Developments
2.9.3. Partnership, Contract/Agreement, & Collaboration
2.10. Impact of COVID-19 on the Clinical Trial Management Market

3. Global Clinical Trial Management Market Outlook - by Deployment Mode

3.1. Web-Based Deployment
3.2. On-Premise Deployment
3.3. Cloud-Based Deployment

4. Global Clinical Trial Management Market Outlook - by Component

4.1. Software
4.2. Hardware
4.3. Services

5. Global Clinical Trial Management Market Outlook - by Product Type

5.1. Enterprise-Based Ctm
5.2. Site-Based Ctm

6. Global Clinical Trial Management Market Outlook - by End-User

6.1. Pharmaceutical & Biopharmaceutical Companies
6.2. Clinical Research Organizations
6.3. Healthcare Providers

7. Global Clinical Trial Management Market - Regional Outlook

7.1. North America
7.1.1. Market by Deployment Mode
7.1.2. Market by Component
7.1.3. Market by Product Type
7.1.4. Market by End-User
7.1.5. Country Analysis
7.1.5.1. United States
7.1.5.2. Canada
7.2. Europe
7.2.1. Market by Deployment Mode
7.2.2. Market by Component
7.2.3. Market by Product Type
7.2.4. Market by End-User
7.2.5. Country Analysis
7.2.5.1. United Kingdom
7.2.5.2. Germany
7.2.5.3. France
7.2.5.4. Spain
7.2.5.5. Italy
7.2.5.6. Russia
7.2.5.7. Rest of Europe
7.3. Asia-Pacific
7.3.1. Market by Deployment Mode
7.3.2. Market by Component
7.3.3. Market by Product Type
7.3.4. Market by End-User
7.3.5. Country Analysis
7.3.5.1. China
7.3.5.2. Japan
7.3.5.3. India
7.3.5.4. South Korea
7.3.5.5. Asean Countries
7.3.5.6. Australia & New Zealand
7.3.5.7. Rest of Asia-Pacific
7.4. Latin America
7.4.1. Market by Deployment Mode
7.4.2. Market by Component
7.4.3. Market by Product Type
7.4.4. Market by End-User
7.4.5. Country Analysis
7.4.5.1. Brazil
7.4.5.2. Mexico
7.4.5.3. Rest of Latin America
7.5. Middle East and Africa
7.5.1. Market by Deployment Mode
7.5.2. Market by Component
7.5.3. Market by Product Type
7.5.4. Market by End-User
7.5.5. Country Analysis
7.5.5.1. United Arab Emirates
7.5.5.2. Turkey
7.5.5.3. Saudi Arabia
7.5.5.4. South Africa
7.5.5.5. Rest of Middle East & Africa

8. Competitive Landscape

8.1. Medidata Solutions Inc
8.2. Arisglobal LLC
8.3. Bioclinica Inc
8.4. Bio-Optronics Inc
8.5. Advarra (Forte Research Systems Inc)
8.6. Oracle Corporation
8.7. IBM Corporation
8.8. Mednet Solutions Inc
8.9. Parexel International Corporation
8.10. Veeva Systems Inc

9. Research Methodology & Scope

9.1. Research Scope & Deliverables
9.1.1. Objectives of Study
9.1.2. Scope of Study
9.2. Sources of Data
9.2.1. Primary Data Sources
9.2.2. Secondary Data Sources
9.3. Research Methodology
9.3.1. Evaluation of Proposed Market
9.3.2. Identification of Data Sources
9.3.3. Assessment of Market Determinants
9.3.4. Data Collection
9.3.5. Data Validation & Analysis

List of Tables

Table 1: Global Clinical Trial Management Market, by Geography, 2021-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Global Clinical Trial Management Market, by Deployment Mode, 2021-2028 (In $ Million)
Table 4: Global Clinical Trial Management Market, by Component, 2021-2028 (In $ Million)
Table 5: Global Clinical Trial Management Market, by Product Type, 2021-2028 (In $ Million)
Table 6: Global Clinical Trial Management Market, by End-User, 2021-2028 (In $ Million)
Table 7: Global Clinical Trial Management Market, by Geography, 2021-2028 (In $ Million)
Table 8: North America Clinical Trial Management Market, by Country, 2021-2028 (In $ Million)
Table 9: North America Clinical Trial Management Market, by Deployment Mode, 2021-2028 (In $ Million)
Table 10: North America Clinical Trial Management Market, by Component, 2021-2028 (In $ Million)
Table 11: North America Clinical Trial Management Market, by Product Type, 2021-2028 (In $ Million)
Table 12: North America Clinical Trial Management Market, by End-User, 2021-2028 (In $ Million)
Table 13: Europe Clinical Trial Management Market, by Country, 2021-2028 (In $ Million)
Table 14: Europe Clinical Trial Management Market, by Deployment Mode, 2021-2028 (In $ Million)
Table 15: Europe Clinical Trial Management Market, by Component, 2021-2028 (In $ Million)
Table 16: Europe Clinical Trial Management Market, by Product Type, 2021-2028 (In $ Million)
Table 17: Europe Clinical Trial Management Market, by End-User, 2021-2028 (In $ Million)
Table 18: Asia-Pacific Clinical Trial Management Market, by Country, 2021-2028 (In $ Million)
Table 19: Asia-Pacific Clinical Trial Management Market, by Deployment Mode, 2021-2028 (In $ Million)
Table 20: Asia-Pacific Clinical Trial Management Market, by Component, 2021-2028 (In $ Million)
Table 21: Asia-Pacific Clinical Trial Management Market, by Product Type, 2021-2028 (In $ Million)
Table 22: Asia-Pacific Clinical Trial Management Market, by End-User, 2021-2028 (In $ Million)
Table 23: Latin America Clinical Trial Management Market, by Country, 2021-2028 (In $ Million)
Table 24: Latin America Clinical Trial Management Market, by Deployment Mode, 2021-2028 (In $ Million)
Table 25: Latin America Clinical Trial Management Market, by Component, 2021-2028 (In $ Million)
Table 26: Latin America Clinical Trial Management Market, by Product Type, 2021-2028 (In $ Million)
Table 27: Latin America Clinical Trial Management Market, by End-User, 2021-2028 (In $ Million)
Table 28: Middle East and Africa Clinical Trial Management Market, by Country, 2021-2028 (In $ Million)
Table 29: Middle East and Africa Clinical Trial Management Market, by Deployment Mode, 2021-2028 (In $ Million)
Table 30: Middle East and Africa Trial Management Market, by Component, 2021-2028 (In $ Million)
Table 31: Middle East and Africa Clinical Trial Management Market, by Product Type, 2021-2028 (In $ Million)
Table 32: Middle East and Africa Clinical Trial Management Market, by End-User, 2021-2028 (In $ Million)

List of Figures

Figure 1: Global Clinical Trial Management Market, by Deployment Mode, 2020 & 2028 (In %)
Figure 2: Porter's Five Forces Analysis
Figure 3: Market Attractiveness Index
Figure 4: Global Clinical Trial Management Market, by Web-Based Deployment, 2021-2028 (In $ Million)
Figure 5: Global Clinical Trial Management Market, by On-Premise Deployment, 2021-2028 (In $ Million)
Figure 6: Global Clinical Trial Management Market, by Cloud-Based Deployment, 2021-2028 (In $ Million)
Figure 7: Global Clinical Trial Management Market, by Software, 2021-2028 (In $ Million)
Figure 8: Global Clinical Trial Management Market, by Hardware, 2021-2028 (In $ Million)
Figure 9: Global Clinical Trial Management Market, by Services, 2021-2028 (In $ Million)
Figure 10: Global Clinical Trial Management Market, by Enterprise-Based Ctm, 2021-2028 (In $ Million)
Figure 11: Global Clinical Trial Management Market, by Site-Based Ctm, 2021-2028 (In $ Million)
Figure 12: Global Clinical Trial Management Market, by Pharmaceutical & Biopharmaceutical Companies, 2021-2028 (In $ Million)
Figure 13: Global Clinical Trial Management Market, by Clinical Research Organizations, 2021-2028 (In $ Million)
Figure 14: Global Clinical Trial Management Market, by Healthcare Providers, 2021-2028 (In $ Million)
Figure 15: Global Clinical Trial Management Market, Regional Outlook, 2020 & 2028 (In %)
Figure 16: United States Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 17: Canada Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 18: United Kingdom Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 19: Germany Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 20: France Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 21: Spain Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 22: Italy Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 23: Russia Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 24: Rest of Europe Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 25: China Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 26: Japan Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 27: India Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 28: South Korea Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 29: Asean Countries Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 30: Australia & New Zealand Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 31: Rest of Asia-Pacific Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 32: Brazil Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 33: Mexico Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 34: Rest of Latin America Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 35: United Arab Emirates Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 36: Turkey Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 37: Saudi Arabia Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 38: South Africa Clinical Trial Management Market 2021-2028 (In $ Million)
Figure 39: Rest of Middle East & Africa Clinical Trial Management Market 2021-2028 (In $ Million)